Get the Stockscreener App
15.46
6.42%
-1.06
After Hours:
15.73
0.27
+1.75%
Eton Pharmaceuticals Inc stock is traded at $15.46, with a volume of 421.22K.
It is down -6.42% in the last 24 hours and down -5.50% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$16.52
Open:
$16.52
24h Volume:
421.22K
Relative Volume:
1.62
Market Cap:
$414.60M
Revenue:
$31.38M
Net Income/Loss:
$-6.69M
P/E Ratio:
-59.46
EPS:
-0.26
Net Cash Flow:
$-1.84M
1W Performance:
-4.92%
1M Performance:
-5.50%
6M Performance:
-1.97%
1Y Performance:
+28.73%
1-Day Range:
$15.33
$16.52
1-Week Range:
$15.33
$17.00
52-Week Range:
$11.09
$23.00
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
15.46 | 443.03M | 31.38M | -6.69M | -1.84M | -0.26 |
|
ZTS
Zoetis Inc
|
127.17 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.31 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.01 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
45.79 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Can Eton Pharmaceuticals Inc. stock attract ESG capital inflowsJuly 2025 Retail & Weekly High Momentum Picks - ulpravda.ru
Why Eton Pharmaceuticals Inc. stock could rally in 20252026 world cup usa national team group stage playmakers transition play group prediction analysis - ulpravda.ru
How (ETON) Movements Inform Risk Allocation Models - Stock Traders Daily
Eton Pharmaceuticals (NASDAQ:ETON) Upgraded at Zacks Research - Defense World
Dental EconomicsEton Pharmaceuticals, Inc.Common Stock (Nasdaq:ETON) Stock Quote - FinancialContent
FDA extends target action date for Eton's ET-400 - MSN
Those who invested in Eton Pharmaceuticals (NASDAQ:ETON) three years ago are up 483% - Yahoo Finance
B. Riley Securities Initiates Coverage of Eton Pharmaceuticals (ETON) with Buy Recommendation - MSN
Understanding Momentum Shifts in (ETON) - Stock Traders Daily
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Is Eton Pharmaceuticals Inc. stock positioned for long term growth2025 Key Lessons & Growth Oriented Trading Recommendations - Улправда
What makes Eton Pharmaceuticals Inc. stock attractive to growth fundsWeekly Stock Report & Weekly High Conviction Ideas - Улправда
Eton Pharmaceuticals, Inc.(NasdaqGM: ETON) added to NASDAQ Biotechnology Index - marketscreener.com
Stock Market Recap: Why Eton Pharmaceuticals Inc. stock could rally in 2025July 2025 Institutional & Reliable Price Action Trade Plans - moha.gov.vn
Will Eton Pharmaceuticals Inc. stock beat EPS estimatesEarnings Beat & Verified Chart Pattern Signals - Улправда
Published on: 2025-12-20 13:06:24 - Улправда
Why Eton Pharmaceuticals Inc. stock could be next big winnerWeekly Trade Summary & Safe Entry Zone Identification - Улправда
Will Eton Pharmaceuticals Inc. stock maintain momentum in 2025Portfolio Gains Report & Free Weekly Watchlist of Top Performers - Bölüm Sonu Canavarı
Can Eton Pharmaceuticals Inc. stock continue upward trendProfit Target & Fast Momentum Stock Entry Tips - DonanımHaber
How Eton Pharmaceuticals Inc. stock trades before earningsJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - DonanımHaber
Published on: 2025-12-19 10:25:25 - Улправда
AI Stocks: Why Eton Pharmaceuticals Inc. stock could be next big winnerJuly 2025 Chart Watch & Consistent Return Investment Signals - Улправда
Aug Big Picture: Why Eton Pharmaceuticals Inc. stock could rally in 2025Profit Target & Stepwise Trade Signal Guides - Улправда
Analysts’ Top Healthcare Picks: Foghorn Therapeutics (FHTX), Eton Pharmaceuticals (ETON) - The Globe and Mail
Highlighting December 2025's Growth Leaders With Insider Ownership - simplywall.st
(ETON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Eton Pharmaceuticals (NASDAQ:ETON) Downgraded by Wall Street Zen to Hold - Defense World
Eton Pharmaceuticals, Inc. (ETON) CCO records 85-share tax withholding transaction - Stock Titan
[Form 4] Eton Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Eton Pharmaceuticals (ETON) CEO details tax-withholding share sale - Stock Titan
FY2025 EPS Estimate for Eton Pharmaceuticals Cut by Analyst - Defense World
What is HC Wainwright's Estimate for ETON FY2025 Earnings? - MarketBeat
Is Now The Right Time To Take A Closer Look At Eton Pharmaceuticals? - RTTNews
HC Wainwright Issues Negative Forecast for ETON Earnings - Defense World
Q4 EPS Forecast for Eton Pharmaceuticals Lowered by Analyst - MarketBeat
Divisadero Street Capital Management LP Purchases New Holdings in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
With Eton Pharmaceuticals Stock Sliding, Have You Assessed The Risk? - Trefis
Geode Capital Management LLC Has $8.45 Million Stock Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Diametric Capital LP Increases Stock Holdings in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Will Eton Pharmaceuticals Inc. stock continue dividend increasesWeekly Stock Report & Weekly Breakout Opportunity Watchlist - Newser
Implied Volatility Surging for Eton Pharmaceuticals Stock Options - sharewise.com
Why Eton Pharmaceuticals Inc. stock is in analyst buy zoneEarnings Risk Report & Risk Controlled Swing Trade Alerts - Newser
Eton Pharmaceuticals Joins Piper Sandler Healthcare Conference - TipRanks
(ETON) Risk Channels and Responsive Allocation - Stock Traders Daily
Is Eton Pharmaceuticals Inc. stock a safe buy before earningsTrade Volume Report & Weekly Market Pulse Updates - Newser
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives $29.67 Average PT from Analysts - Defense World
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Aristides Capital LLC Has $2.39 Million Stock Holdings in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Is Eton Pharmaceuticals Inc. stock a buy on dipsPortfolio Update Summary & Weekly Sector Rotation Insights - moha.gov.vn
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):